Skip to main content

Profiles

Aileron Therapeutics

Aileron Therapeutics is an American biopharmaceutical company based in Cambridge, Massachusetts.

Organization

Name Position Notes
Loren Walensky Scientific Advisory Board member and consultant[1] Rochelle Walensky, Dana-Farber Cancer Institute, Lytica Therapeutics

Investors

Investors in Aileron Therapeutics include:[2][3][4][5]

  • Acorn Bioventures
  • Aju IB Investment
  • Apple Tree Partners
  • BVF Partners
  • CB Health Ventures
  • Eli Lilly
  • Excel Venture Management
  • Grand Oaks Capital
  • Lincoln Park Capital Fund
  • Maven Investment Partners
  • Novartis Venture Fund (NVF)
  • Roche
  • Satter Investment Management
  • SR One

  1. Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019). Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Nature Biotechnology, 37(10), 1186–1197. https://doi.org/10.1038/s41587-019-0222-z ↩︎

  2. Aileron Therapeutics - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/organization/aileron-therapeutics/company_financials ↩︎

  3. Series A - Aileron Therapeutics - 2006-12-01 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-a--f1823f7a ↩︎

  4. Series D - Aileron Therapeutics - 2009-06-11 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-d--7c3c2e71 ↩︎

  5. Series E - Aileron Therapeutics - 2014-10-29 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-e--740ce9be ↩︎